Wilmington, DE, United States of America

James B Campbell

This inventor holds 7 USPTO granted patents and 4 published patent applications. Top assignees: Ici Americas, Inc., Astrazeneca Ab, Other. Active years: 1978-2013.

USPTO Granted Patents = 7 (Patent Applications = 4)

% Patents Active = 85.7

Average Co-Inventor Count = 1.4

ph-index = 5

Forward Citations = 79(Granted Patents)

Location History:

Warren, MI (US) (1978)
Malvern, PA (US) (1982 - 1985)
Chadds Ford, PA (US) (1990 - 1992)
Wilmington, DE (US) (1986 - 2013)

Company Filing History:

2 out of 834,411

Other

patents

Years Active: 1978-2013

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8389510 - Crystalline forms (2013-03-05),

2. 5118688 - Tetrahydropyridoquinolone derivatives useful as anxiolytic agents (1992-06-02),

3. 4975435 - Certain 1H-pyrrold[3,4-b]quinolin-1-one-9-amino-2,3-dihydro derivatives (1990-12-04),

4. 4563525 - Process for preparing pyrazolopyridine compounds (1986-01-07),

5. 4546104 - Pyrazolopyridine cycloalkanones and process for their preparation (1985-10-08),

6. 4334683 - Disc game apparatus (1982-06-15),

7. 4066250 - Ski clamping apparatus (1978-01-03),

Title: The Innovative Contributions of James B. Campbell

Introduction

James B. Campbell is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the "Crystalline forms - 11-piperazin-1-yldibenzo[b,f][1,4]thiazepine, compositions thereof, preparations thereof, formulations thereof, prodrugs thereof and pharmaceutical uses thereof." This invention aims to enhance the efficacy and usability of this compound in medical applications. Another significant patent is for "Tetrahydropyridoquinolone derivatives useful as anxiolytic agents." This invention includes certain quinoline lactams and their pharmaceutically acceptable salts, which are intended for the treatment of anxiety.

Career Highlights

James has worked with various companies throughout his career, including Ici Americas, Inc. His experience in the pharmaceutical industry has allowed him to develop and patent innovative solutions that address critical health issues.

Collaborations

James has collaborated with notable professionals in his field, including Simon Nicholas Black and Scott W. Grimm. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

James B. Campbell's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through his inventive work. His patents reflect a deep understanding of medicinal chemistry and a dedication to addressing the needs of patients.